[1]
Azoulay, L.-D. et al. 2020. Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis: Implantable cardioverter defibrillators in cardiac sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 37, 1 (Mar. 2020), 17–23. DOI:https://doi.org/10.36141/svdld.v37i1.8271.